Lonza Group AG (LZAGF)
643.25
-24.85
(-3.72%)
USD |
OTCM |
Dec 12, 15:52
Lonza Group Market Cap: 45.12B for Dec. 12, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| BeOne Medicines Ltd. | 35.30B |
| AC Immune SA | 318.40M |
| CRISPR Therapeutics AG | 5.403B |
| Addex Therapeutics Ltd. | 9.474M |
| NewCelX Ltd. | 1.323M |
Market Cap Related Metrics
| PE Ratio | 54.55 |
| PS Ratio | 5.673 |
| Price | 643.25 |
| Earnings Yield | 1.83% |
| Operating PE Ratio | 36.62 |
| Normalized PE Ratio | 50.06 |